114 related articles for article (PubMed ID: 24726705)
1. Intrathecal injection of selected peptide Myr-RC-13 attenuates bone cancer pain by inhibiting KIF17 and NR2B expression.
Ni K; Zhou Y; Sun YE; Liu Y; Gu XP; Ma ZL
Pharmacol Biochem Behav; 2014 Jul; 122():228-33. PubMed ID: 24726705
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal injection of the peptide myr-NR2B9c attenuates bone cancer pain via perturbing N-methyl-D-aspartate receptor-PSD-95 protein interactions in mice.
Liu Y; Cui X; Sun YE; Yang X; Ni K; Zhou Y; Ma Z; Gu X
Anesth Analg; 2014 Jun; 118(6):1345-54. PubMed ID: 24842180
[TBL] [Abstract][Full Text] [Related]
3. The inhibitor of calcium/calmodulin-dependent protein kinase II KN93 attenuates bone cancer pain via inhibition of KIF17/NR2B trafficking in mice.
Liu Y; Liang Y; Hou B; Liu M; Yang X; Liu C; Zhang J; Zhang W; Ma Z; Gu X
Pharmacol Biochem Behav; 2014 Sep; 124():19-26. PubMed ID: 24836181
[TBL] [Abstract][Full Text] [Related]
4. Kinesin superfamily protein 17 contributes to the development of bone cancer pain by participating in NR2B transport in the spinal cord of mice.
Liu M; Liu Y; Hou B; Bu D; Shi L; Gu X; Ma Z
Oncol Rep; 2015 Mar; 33(3):1365-71. PubMed ID: 25573412
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal administration of roscovitine attenuates cancer pain and inhibits the expression of NMDA receptor 2B subunit mRNA.
Zhang R; Liu Y; Zhang J; Zheng Y; Gu X; Ma Z
Pharmacol Biochem Behav; 2012 Jul; 102(1):139-45. PubMed ID: 22503970
[TBL] [Abstract][Full Text] [Related]
6. The role of N-methyl-D-aspartate receptor subunit NR2B in spinal cord in cancer pain.
Gu X; Zhang J; Ma Z; Wang J; Zhou X; Jin Y; Xia X; Gao Q; Mei F
Eur J Pain; 2010 May; 14(5):496-502. PubMed ID: 19815434
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal administration of the cannabinoid 2 receptor agonist JWH015 can attenuate cancer pain and decrease mRNA expression of the 2B subunit of N-methyl-D-aspartic acid.
Gu X; Mei F; Liu Y; Zhang R; Zhang J; Ma Z
Anesth Analg; 2011 Aug; 113(2):405-11. PubMed ID: 21519057
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of REST on NR2B in spinal cord contributes to the development of bone cancer pain in mice.
Wang D; Yu J
Oncotarget; 2016 Dec; 7(51):85564-85572. PubMed ID: 27732941
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the spinal NMDA receptor/PKCγ signaling pathway in the development of bone cancer pain.
Xiaoping G; Xiaofang Z; Yaguo Z; Juan Z; Junhua W; Zhengliang M
Brain Res; 2010 Jun; 1335():83-90. PubMed ID: 20362561
[TBL] [Abstract][Full Text] [Related]
10. CREB-regulated transcription coactivator 1 enhances CREB-dependent gene expression in spinal cord to maintain the bone cancer pain in mice.
Liang Y; Liu Y; Hou B; Zhang W; Liu M; Sun YE; Ma Z; Gu X
Mol Pain; 2016; 12():. PubMed ID: 27060162
[TBL] [Abstract][Full Text] [Related]
11. Perturbing NR2B-PSD-95 interaction relieves neuropathic pain by inactivating CaMKII-CREB signaling.
Xu F; Zhao X; Liu L; Song J; Zhu Y; Chu S; Shao X; Li X; Ma Z; Gu X
Neuroreport; 2017 Sep; 28(13):856-863. PubMed ID: 28746067
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model.
Ren BX; Gu XP; Zheng YG; Liu CL; Wang D; Sun YE; Ma ZL
Anesthesiology; 2012 Jan; 116(1):122-32. PubMed ID: 22123524
[TBL] [Abstract][Full Text] [Related]
13. Analgesic Effect of Intrathecal Administration of Chemokine Receptor CCR2 Antagonist is Related to Change in Spinal NR2B, nNOS, and SIGIRR Expression in Rat with Bone Cancer Pain.
Ren F; Jiao H; Cai H
Cell Biochem Biophys; 2015 Jun; 72(2):611-6. PubMed ID: 25653100
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous inhibition of NMDA and mGlu1/5 receptors by levo-corydalmine in rat spinal cord attenuates bone cancer pain.
Dai WL; Yan B; Jiang N; Wu JJ; Liu XF; Liu JH; Yu BY
Int J Cancer; 2017 Aug; 141(4):805-815. PubMed ID: 28500623
[TBL] [Abstract][Full Text] [Related]
15. The spinal NR2BR/ERK2 pathway as a target for the central sensitization of collagen-induced arthritis pain.
Xu Y; Zhang K; Miao J; Zhao P; Lv M; Li J; Fu X; Luo X; Zhu P
PLoS One; 2018; 13(7):e0201021. PubMed ID: 30024967
[TBL] [Abstract][Full Text] [Related]
16. Mas-Related Gene (Mrg) C Activation Attenuates Bone Cancer Pain via Modulating Gi and NR2B.
Sun Y; Jiang M; Hou B; Lu C; Lei Y; Ma Z; Gu X
PLoS One; 2016; 11(5):e0154851. PubMed ID: 27152740
[TBL] [Abstract][Full Text] [Related]
17. The effect of NR2B subunit palmitoylation at the spinal level after chronic dorsal root ganglia compression in rats.
Xia T; Cui Y; Shi H; Ma Z; Gu X
Anesth Analg; 2014 Nov; 119(5):1208-14. PubMed ID: 25089731
[TBL] [Abstract][Full Text] [Related]
18. Modulation of KIF17/NR2B crosstalk by tozasertib attenuates inflammatory pain in rats.
Uniyal A; Gadepalli A; Modi A; Tiwari V
Inflammopharmacology; 2022 Apr; 30(2):549-563. PubMed ID: 35243557
[TBL] [Abstract][Full Text] [Related]
19. KIF17 dynamics and regulation of NR2B trafficking in hippocampal neurons.
Guillaud L; Setou M; Hirokawa N
J Neurosci; 2003 Jan; 23(1):131-40. PubMed ID: 12514209
[TBL] [Abstract][Full Text] [Related]
20. Blocking EphB1 receptor forward signaling in spinal cord relieves bone cancer pain and rescues analgesic effect of morphine treatment in rodents.
Liu S; Liu WT; Liu YP; Dong HL; Henkemeyer M; Xiong LZ; Song XJ
Cancer Res; 2011 Jul; 71(13):4392-402. PubMed ID: 21555368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
